---
layout: post
title: "RARE Investors Have Opportunity to Lead Ultragenyx Pharmaceutical Inc. Securities Fraud Lawsuit with the Schall Law Firm"
date: 2026-02-23T09:06:00+00:00
source: PR Newswire Releases
source_url: https://www.prnewswire.com/news-releases/rare-investors-have-opportunity-to-lead-ultragenyx-pharmaceutical-inc-securities-fraud-lawsuit-with-the-schall-law-firm-302694328.html
significance: 9.00
---

<p>LOS ANGELES, Feb. 23, 2026 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Ultragenyx Pharmaceutical Inc. ("Ultragenyx" or "the Company") (NASDAQ: RARE) for violations of §§10(b) and 20(a) of the...</p>

**Source:** [PR Newswire Releases](https://www.prnewswire.com/news-releases/rare-investors-have-opportunity-to-lead-ultragenyx-pharmaceutical-inc-securities-fraud-lawsuit-with-the-schall-law-firm-302694328.html)

**Published:** 2026-02-23 09:06:00 +0000

**Significance Score:** 9.00

[View original](https://www.prnewswire.com/news-releases/rare-investors-have-opportunity-to-lead-ultragenyx-pharmaceutical-inc-securities-fraud-lawsuit-with-the-schall-law-firm-302694328.html)
